PHOENIX (CN) — A former research director at C.R. Bard defended the medical technology company in federal court Wednesday from accusations it neglected viable new technologies that could have prevented infections in patients with implanted port catheters.
Though patients in more than 3,000 federal lawsuits claim otherwise, medical engineer Kelly Christian said Bard, a subsidiary of Becton Dickinson and Company, tested and evaluated numerous products designed to prevent port catheter infections, but none proved safe enough for human use.
Additional Reads
Read Full Article: https://www.courthousenews.com/leading-catheter-company-fights-negligence-claims-in-federal-trial/
